Cargando…
Pharmacoeconomics of three Therapeutic Schemes for Anti-tuberculosis Therapy Induced Liver Injury in China
To evaluate the pharmacoeconomics of three therapeutic schemes in treating anti-tuberluosis therapy -induced liver injury (anti-TB DILI). METHODS: In the construction of a decision tree model, the efficacy and safety parameters came from the results of the randomized, controlled trial conducted here...
Autores principales: | Chen, Yu, Ye, Peng, Ren, Chongwu, Ren, Pengfei, Ma, Zheng, Zhang, Lin, Zhou, Wenliang, Jiang, Changjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter Open
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874510/ https://www.ncbi.nlm.nih.gov/pubmed/29607414 http://dx.doi.org/10.1515/med-2018-0010 |
Ejemplares similares
-
Essentials of pharmacoeconomics
por: Rascati, Karen L.
Publicado: (2014) -
Principles of pharmacoeconomics /
Publicado: (1996) -
Quality of pharmacoeconomic research in China: A systematic review
por: Ma, Huifen, et al.
Publicado: (2016) -
Pharmacoeconomics in COPD: lessons for the future
por: Starkie, Helen J, et al.
Publicado: (2008) -
Fluid management: the pharmacoeconomic dimension
por: Vincent, Jean-Louis
Publicado: (2000)